首页> 外国专利> RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /SINA)

RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /SINA)

机译:RNA干扰介导的短干扰核酸/新浪抑制胆碱能肌腱受体(CHRM3)基因表达

摘要

This invention relates to compounds, compositions, and methods useful formodulating cholinergic muscarinic receptor gene expression using shortinterfering nucleic acid (siNA) molecules. This invention also relates tocompounds, compositions, and methods useful for modulating the expression andactivity of other genes involved in pathways of cholinergic muscarinicreceptor gene expression and/or activity by RNA interference (RNAi) usingsmall nucleic acid molecules. In particular, the instant invention featuressmall nucleic acid molecules, such as short interfering nucleic acid (siNA),short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA),and short hairpin RNA (shRNA) molecules and methods used to modulate theexpression of cholinergic muscarinic receptor genes, such as M3 muscarinicacetylcholine receptor or cholinergic receptor muscarinic 3 (CHRM3).
机译:本发明涉及可用于短时调节胆碱能毒蕈碱受体基因表达干扰核酸(siNA)分子。本发明还涉及化合物,组合物和方法可用于调节表达和参与胆碱能毒蕈碱途径的其他基因的活性受体基因表达和/或RNA干扰(RNAi)的活性小核酸分子。特别地,本发明的特征在于小核酸分子,例如短干扰核酸(siNA),短干扰RNA(siRNA),双链RNA(dsRNA),微小RNA(miRNA),和短发夹RNA(shRNA)分子以及用于调节毒蕈碱能受体基因如M3毒蕈碱的表达乙酰胆碱受体或胆碱能受体毒蕈碱3(CHRM3)。

著录项

  • 公开/公告号CA2542527A1

    专利类型

  • 公开/公告日2005-05-19

    原文格式PDF

  • 申请/专利权人 SIRNA THERAPEUTICS INC.;

    申请/专利号CA20042542527

  • 发明设计人 RICHARDS IVAN;MCSWIGGEN JAMES;

    申请日2004-08-20

  • 分类号C12N15/11;A01N43/04;A61K31/713;C07H21/02;C07H21/04;C12P19/34;

  • 国家 CA

  • 入库时间 2022-08-21 22:13:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号